Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
261studies shown
Showing 13-24 of 261
Drug study icon
OngoingEUCTR 2022-000430-42

Safety study of aticaprant in depression

This study is ongoing in France, in Belgium, in Sweden, .... It is testing aticaprant for depression.

In France
Why is this study shown?

This study is directly about Depression.

DepressionOther
Countries
France, Belgium, Sweden, ...
Sponsor
Janssen-Cilag International NV
Condition
Depression
Device study icon
RecruitingNCT04956016

Effects of a Classic High-frequency rTMS Treatment Versus a Deep rTMS Treatment

This study is looking at demonstrate that dTMS is more efficient than high frequency rTMS with a conventional coil for people with depression, Treatment-Resistant. Participants take part in classic rTMS using the 8-shaped coil and complete follow-up assessments.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
France
Sponsor
Centre Hospitalier Henri Laborit
Condition
Depression
Other study type icon
RecruitingISRCTN49376288

Efficacy of agomelatine given orally on rest/activity circadian rhythms in outpatients with major depressive disorder: a international study with parallel groups versus Selective Serotonin Reuptake Inhibitor (SSRI). Six-week treatment plus optional continuation for 18 weeks.

This study is recruiting in France, in Austria, in Germany, .... It focuses on depression.

In France
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 60 Years
Countries
France, Austria, Germany, ...
Sponsor
Institut de Recherches Internationales Servier (France)
Condition
Depression
Drug study icon
RecruitingNCT05866575

Prediction of the Therapeutic Response in Depression Based on Neuro-computational Modeling Assessment of Motivation

This study is looking at better understand the mechanisms of action of antidepressants, but also the neural correlates of motivation deficits for people with depression. Participants receive a study treatment and complete follow-up visits and assessments.

In France
Why is this study shown?

This study is directly about Depression.

DepressionOtherOver 18 Years
Countries
France
Sponsor
Centre Hospitalier St Anne
Condition
Depression
Behavioral study icon
RecruitingNCT06183359

Self-Identification Program

This study is looking at whether a digital support tool can help people with depression or Third Wave Cognitive Behavioral Therapy. Participants receive a study treatment and complete follow-up visits and assessments.

In France
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 70 Years
Countries
France
Sponsor
University Hospital, Montpellier
Condition
Depression
Behavioral study icon
RecruitingNCT06740331

Social Cognition, Memory, and Executive Functions in Bipolarity and Major Depressive Disorder

This study is looking at care and outcomes for people with bipolarity and depression. Some participants may receive Bipolar controls instead of the study treatment, and direct benefit is not guaranteed.

In France
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityBehavioralFrom 18 Years to 65 Years
Countries
France
Sponsor
CHU de Reims
Condition
Depression, Bipolarity
Drug study icon
RecruitingNCT05850689

Lumateperone as Adjunctive Therapy in the Treatment of people with Major Depressive Disorder

This study is comparing Lumateperone with placebo for people with depression. Participants receive Lumateperone or placebo and complete study visits and assessments.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Depression
Drug study icon
RecruitingNCT06833788

Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression

This observational study is following people with Postpartum Depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
Depression
Drug study icon
RecruitingISRCTN28588282

Agomelatine given orally compared to placebo, for depression

This study is recruiting in France. It is testing agomelatine given orally compared to placebo, for depression.

In France
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityOtherOver 18 Years
Countries
France
Sponsor
Institut de Recherches Internationales Servier (France)
Condition
Depression, Bipolarity
Other study type icon
RecruitingISRCTN73157235

Effects of a prenatal program group led to parental couples to prevent postpartum depression in women of middle and lower classes living in northern Catalonia and Southern France [Effetsd’unprogrammeprénatal de groupeadresséauxcouplesparentauxpourprévenir la dépressionpostnatale des femmes de clases moyenne et défavoriséehabitant en Catalogne Nord et en France Sud]

This study is recruiting in France and in Spain. It focuses on depression.

In France
Why is this study shown?

This study is directly about Depression.

DepressionOther
Countries
France, Spain
Sponsor
ADERMNCN (Association for better childbirth in Northern Catalonia) (Spain)
Condition
Depression
Behavioral study icon
Not Yet RecruitingNCT07120880

Efficacy of Chronotherapeutic Combination for Major Depressive Episode With Insomnia

This study is comparing AD + SHR + active LT and extended-release melatonin 2mg with placebo for people with depression With Insomnia. Participants receive AD + SHR + active LT and extended-release melatonin 2mg or placebo and complete study visits and assessments.

In France
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.